

Health Care: Drugs
MannKind Corporation (MNKD: NASDAQ)
$6.23 0.87 | 16.23%
05/22/13 - 04:00 PM ET
Insider Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Net Insider Transaction |
-19,774 |
-19,774 |
0 |
0 |
221,640 |
221,640 |
31.47M |
| Shares Bought |
0 |
0 |
0 |
0 |
243,500 |
243,500 |
31.49M |
| Shares Sold |
19,774 |
19,774 |
0 |
0 |
21,860 |
21,860 |
21,860 |
Institutional Trading
 |
| Historical Data |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
4 Mo. Ago |
5 Mo. Ago |
6 Mo. Ago |
| Total Shares Held |
39.00M |
38.88M |
40.27M |
41.62M |
30.92M |
28.77M |
28.91M |
| Shares Bought |
9.86M |
11.88M |
13.58M |
13.60M |
5.12M |
3.08M |
3.16M |
| Shares Sold |
4.86M |
2.04M |
886,481 |
866,810 |
3.32M |
3.77M |
3.24M |
Partner Headlines for MNKD
- Mid-Afternoon Market Update: Markets Remain Down, Bankrate Rallies - Benzinga 04.12.13 | 03:04 pm
- Long MannKind's Afrezza: Shares Versus A Bull Call Spread - Seeking Alpha 12.01.12 | 07:12 am
- MannKind to Raise Funds - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- MannKind Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- MNKD Enrolls Patients for Afrezza - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- Company News for September 05, 2012 - Corporate Summary - NASDAQ 09.05.12 | 02:09 pm
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Top Insider Buys: HRB, LPI, GCO, GAM, SONC, MNKD - GuruFocus 07.09.12 | 01:07 pm
- A123 Systems POPS to Lead 7 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.21.12 | 11:06 am
- MNKD Cancer Treatment Data Released - Analyst Blog - Zacks 06.01.12 | 06:06 pm